The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: Epidemiology and pathogenesis

Medical Clinics of North America

Volumn 89, Issue 2, 2005, Pages 371-389

  Hayashi, Paul H ^a   Di Bisceglie, Adrian M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; SOMATOMEDIN B; VIRUS DNA; VIRUS RNA;

CANCER RISK; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; ETHNOLOGY; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOSITY LOSS; HUMAN; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RNA ANALYSIS; SEROCONVERSION; VIRUS GENOME; VIRUS TRANSMISSION;

CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DISEASE PROGRESSION; HEPATITIS B; HEPATITIS C; HUMANS; LIVER DISEASES; LIVER NEOPLASMS;

EID: 12344306295     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.08.014     Document Type: Review

References (68)

1. S. Krugman, J.P. Giles, and J. Hammond Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection JAMA 200 1967 365 373
2. B.S. Blumberg, H.J. Alter, and S. Visnich A "new" antigen in leukemia sera JAMA 191 1965 541 546
3. B.S. Blumberg, A.I. Sutnick, W.T. London, and I. Millman Australia antigen and hepatitis N Engl J Med 283 1970 349 354
4. D.S. Dane, C.H. Cameron, and M. Briggs Virus-like particles in serum of patients with Australia-antigen-associated hepatitis Lancet 1 1970 695 698
5. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
6. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C: 2002-June 10-12, 2002 Hepatology 36 2002 S3 S20
7. H.B. El-Serag Epidemiology of hepatocellular carcinoma Clin Liver Dis 5 2001 87 107
8. A.M. Di Bisceglie Malignant tumors of the liver E.R. Schiff M.F. Sorrell W.C. Maddrey Schiffs diseases of the liver 8th edition 1999 Lippincott-Raven Philadelphia 1281 1304
9. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, and C.J. Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
10. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
11. J.A. Marrero, R.J. Fontana, G.L. Su, H.S. Conjeevaram, D.M. Emick, and A.S. Lok NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 2002 1349 1354
12. Y.C. Chen, I.S. Sheen, C.M. Chu, and Y.F. Liaw Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with and without concurrent infection Gastroenterology 123 2002 1084 1089
13. A.M. Prince, W. Szmuness, J. Michon, J. Demaille, G. Diebolt, and J. Linhard A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal Int J Cancer 16 1975 376 383
14. M.J. Simons, E.H. Yap, M. Yu, and K. Shanmugaratnam Australia antigen in Singapore Chinese patients with hepatocellular carcinoma and comparison groups: influence of technique sensitivity on differential frequencies Int J Cancer 10 1972 320 325
15. R.P. Beasley, L.Y. Hwang, C.C. Lin, and C.S. Chien Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan Lancet 2 1981 1129 1133
16. R.P. Beasley Hepatitis B: the major etiology of hepatocellular carcinoma Cancer 61 1988 1942 1956
17. M. Colombo, and P. Lampertico Natural history of chronic hepatitis B and hepatocellular carcinoma A.J. Zuckerman H.C. Thomas Viral hepatitis 2nd edition 1998 Churchill Livingstone London 173 178
18. M.H. Chang, C.J. Chen, M.S. Lai, H.M. Hsu, T.C. Wu, and M.S. Kong Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children N Engl J Med 336 1997 1855 1859
19. P. Coursaget, B. Yvonnet, J. Chotard, P. Vincelot, M. Sarr, and C. Diouf Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal) J Med Virol 22 1987 1 5
20. R.P. Beasley, L.Y. Hwang, C.C. Lin, M.L. Leu, C.E. Stevens, and W. Szmuness Incidence of hepatitis B virus infections in preschool children in Taiwan J Infect Dis 146 1982 198 204
21. B.J. McMahon, W.L. Alward, D.B. Hall, W.L. Heyward, T.R. Bender, and D.P. Francis Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state J Infect Dis 151 1985 599 603
22. G.W. Beebe, and J.E. Norman Study of the likelihood of hepatocellular carcinoma following the 1942 US Army epidemic of hepatitis B E. Tabor A.M. Di Bisceglie R.H. Purcell Etiology, pathology and treatment of hepatocellular carcinoma in North America. Advances in Applied Biotechnology Series 1991 Gulf Publishing Houston (TX) 3 15
23. United States Immigration and Naturalization (INS) website. Available at: http://uscis.gov/graphics/index.htm. Accessed June 7, 2001.
24. US Census Bureau. Statistical abstract of the United States. Available at: http://www.census.gov/statab/www/. Accessed June 7, 2001.
25. M.J. Tong, and S.J. Hwang Hepatitis B virus infection in Asian Americans Gastroenterol Clin North Am 23 1994 523 536
26. M.J. Tong, R.R. Schwindt, G.H. Lo, and R.L. Co Chronic hepatitis and hepatocellular carcinoma in Asian Americans E. Tabor A.M. Di Bisceglie R.H. Purcell Etiology, pathology and treatment of hepatocellular carcinoma in North America. Advances in Applied Biotechnology Series 1991 Gulf Publishing Houston (TX) 15 23
27. R.K. Ross, J.M. Yuan, M.C. Yu, G.N. Wogan, G.S. Qian, and J.T. Tu Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma Lancet 339 1992 943 946
28. G.S. Qian, R.K. Ross, M.C. Yu, J.M. Yuan, Y.T. Gao, and B.E. Henderson A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China Cancer Epidemiol Biomarkers Prev 3 1994 3 10
29. Y. Fujimoto, L.L. Hampton, L.D. Luo, P.J. Wirth, and S.S. Thorgeirsson Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates Cancer Res 52 1992 1044 1046
30. C.J. Chen, K.Y. Liang, A.S. Chang, Y.C. Chang, S.N. Lu, and Y.F. Liaw Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma Hepatology 13 1991 398 406
31. M.M. Hassan, L.Y. Hwang, C.J. Hatten, M. Swaim, D. Li, and J.L. Abbruzzese Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 2002 1206 1213
32. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
33. K. Okuda, I. Fujimoto, A. Hanai, and Y. Urano Changing incidence of hepatocellular carcinoma in Japan Cancer Res 47 1987 4967 4972
34. H. Yoshizawa Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future Oncology 62 Suppl 1 2002 8 17
35. H.B. El-Serag Hepatocellular carcinoma and hepatitis C in the United States Hepatology 36 Suppl 1 2002 S74 S83
36. M. Colombo, G. Kuo, Q.L. Choo, M.F. Donato, E. Del Ninno, and M.A. Tommasini Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma Lancet 2 1989 1006 1008
37. P. Fasani, A. Sangiovanni, C. De Fazio, M. Borzio, S. Bruno, and G. Ronchi High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors Hepatology 29 1999 1704 1707
38. T. Stroffolini, P. Andreone, A. Andriulli, A. Ascione, A. Craxi, and M. Chiaramonte Gross pathologic types of hepatocellular carcinoma in Italy Oncology 56 1999 189 192
39. F. Donato, P. Boffetta, and M. Puoti A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma Int J Cancer 75 1998 347 354
40. M.J. Alter, D. Kruszon-Moran, O.V. Nainan, G.M. McQuillan, F. Gao, and L.A. Moyer The prevalence of hepatitis C virus infection in the United States, 1988-1994 N Engl J Med 341 1999 556 562
41. I. Williams Epidemiology of hepatitis C in the United States Am J Med 107 1999 2S 9S
42. Centers for Disease Control and Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR Recomm Rep 47 RR-19 1998 1 39
43. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C: 2002 - June 10-12, 2002 Hepatology 36 2002 S3 S20
44. L.B. Seeff Natural history of hepatitis C Hepatology 36 2002 S35 S46
45. M. Wiese, F. Berr, M. Lafrenz, H. Porst, U. Oesen, and for the East Germany Hepatitis C Study Group Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20 year multicenter study Hepatology 32 2000 91 96
46. T.J. Liang, B. Rehermann, L.B. Seeff, and J.H. Hoofnagle Pathogenesis, natural history, treatment, and prevention of hepatitis C Ann Intern Med 132 2000 296 305
47. A.T. De Souza, G.R. Hankins, M.K. Washington, T.C. Orton, and R.L. Jirtle M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity Nat Genet 11 1995 447 449
48. T. Yamada, A.T. De Souza, S. Finkelstein, and R.L. Jirtle Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis Proc Natl Acad Sci U S A 94 1997 10351 10355
49. Y. Oka, R.A. Waterland, J.K. Killian, C.M. Nolan, H.S. Jang, and K. Tohara M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan Hepatology 35 2002 1153 1163
50. L.E. Young, K. Fernandes, T.G. McEvoy, S.C. Butterwith, C.G. Gutierrez, and C. Carolan Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture Nat Genet 27 2001 153 154
51. B. Motyka, G. Korbutt, M.J. Pinkoski, J.A. Heibein, A. Caputo, and M. Hobman Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis Cell 103 2000 491 500
52. M. Roncalli, P. Bianchi, B. Bruni, L. Laghi, A. Destro, and S. Di Gioia Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma Hepatology 36 2002 427 432
53. Y. Kondo, Y. Kanai, M. Sakamoto, M. Mizokami, R. Ueda, and S. Hirohashi Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis: a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma Hepatology 32 2000 970 979
54. W. Fang, Z. Piao, D. Simon, J.C. Sheu, and S. Huang Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region Genes Chromosomes Cancer 28 2000 269 275
55. Y. Kanai, S. Ushijima, H. Tsuda, M. Sakamoto, and S. Hirohashi Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis Cancer Lett 148 2000 73 80
56. K.H. Buetow, J.C. Murray, J.L. Israel, W.T. London, M. Smith, and M. Kew Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma Proc Natl Acad Sci U S A 86 1989 8852 8856
57. Z. Piao, C. Park, J.H. Park, and H. Kim Allelotype analysis of hepatocellular carcinoma Int J Cancer 75 1998 29 33
58. Y. Yumoto, T. Hanafusa, H. Hada, T. Morita, S. Ooguchi, and N. Shinji Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma J Gastroenterol Hepatol 10 1995 179 185
59. K.A. McGlynn, M.N. Edmonson, R.A. Michielli, W.T. London, W.Y. Lin, and G.C. Chen A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas Hepatology 36 2002 1341 1348
60. G. Fourel, C. Trepo, L. Bougueleret, B. Henglein, A. Ponzetto, and P. Tiollais Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours Nature 347 1990 294 298
61. T.M. Block, A.S. Mehta, C.J. Fimmel, and R. Jordan Molecular viral oncology of hepatocellular carcinoma Oncogene 22 2003 5093 5097
62. M.A. Feitelson Hepatitis B virus in hepatocarcinogenesis J Cell Physiol 181 1999 188 202
63. C.G. Wu, M. Forgues, S. Siddique, J. Farnsworth, K. Valerie, and X.W. Wang SAGE transcript profiles of normal primary human hepatocytes expressing oncogenic hepatitis B virus X protein FASEB J 16 2002 1665 1667
64. C.T. Yeh Hepatitis B virus X protein: searching for a role in hepatocarcinogenesis J Gastroenterol Hepatol 15 2000 339 341
65. M. Vogt, T. Lang, G. Frosner, C. Klingler, A.F. Sendl, and A. Zeller Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening N Engl J Med 341 1999 866 870
66. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 2002 S21 S29
67. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
68. K. Moriya, H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, and K. Ishibashi The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat Med 4 1998 1065 1067